371 related articles for article (PubMed ID: 22304663)
1. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
Aydogdu A; Tasci I; Tapan S; Basaran Y; Aydogan U; Meric C; Sonmez A; Aydogdu S; Akbulut H; Taslipinar A; Uckaya G; Azal O
Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
[TBL] [Abstract][Full Text] [Related]
2. Women with polycystic ovary syndrome have increased plasma chitotriosidase activity: a pathophysiological link between inflammation and impaired insulin sensitivity?
Aydogdu A; Tasci I; Tapan S; Sonmez A; Aydogan U; Akbulut H; Uckaya G; Aydogdu S; Basaran Y; Meric C; Taslipinar A; Kurt I; Azal O
Exp Clin Endocrinol Diabetes; 2012 May; 120(5):261-5. PubMed ID: 22549343
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
4. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.
Hu W; Qiao J; Yang Y; Wang L; Li R
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):53-6. PubMed ID: 21530057
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
6. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
7. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
Verit FF
Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
[TBL] [Abstract][Full Text] [Related]
8. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
[TBL] [Abstract][Full Text] [Related]
9. Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance.
Bahceci M; Tuzcu A; Canoruc N; Tuzun Y; Kidir V; Aslan C
Horm Res; 2004; 62(6):283-7. PubMed ID: 15542929
[TBL] [Abstract][Full Text] [Related]
10. Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.
Moradi S; Mollabashi M; Kerman SR
Gynecol Endocrinol; 2011 Jul; 27(7):480-5. PubMed ID: 20836727
[TBL] [Abstract][Full Text] [Related]
11. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
Wan DH; Fan P; Bai H; Song Q; Liu HW
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
[TBL] [Abstract][Full Text] [Related]
12. Obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan.
Wu DM; Chu NF; Shen MH; Wang SC
Clin Biochem; 2006 Aug; 39(8):810-5. PubMed ID: 16814764
[TBL] [Abstract][Full Text] [Related]
13. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
15. Is pentraxin 3 a new cardiovascular risk marker in polycystic ovary syndrome?
Sari U; Kaygusuz I; Kafali H
Gynecol Obstet Invest; 2014; 78(3):173-8. PubMed ID: 25011417
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
Bahceci M; Aydemir M; Tuzcu A
Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
[TBL] [Abstract][Full Text] [Related]
17. The association between pentraxin 3 and insulin resistance in obese children at baseline and after physical activity intervention.
Chu SH; Park JH; Lee MK; Jekal Y; Ahn KY; Chung JY; Lee DH; Kim ES; Naruse M; Im JA; Kong ID; Chung CH; Lee JW; Chung KM; Kim YB; Jeon JY
Clin Chim Acta; 2012 Oct; 413(19-20):1430-7. PubMed ID: 22687644
[TBL] [Abstract][Full Text] [Related]
18. Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome.
Cakal E; Ustun Y; Engin-Ustun Y; Ozkaya M; Kilinç M
Gynecol Endocrinol; 2011 Jul; 27(7):491-5. PubMed ID: 20626239
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
Alemzadeh R; Kichler J; Calhoun M
Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]